These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess. Colombo P, Passini E, Re T, Faglia G, Ambrosi B. Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696 [Abstract] [Full Text] [Related]
44. Effect of single doses of dexamethasone and adrenocorticotrop hormone on serum bone markers in healthy subjects and in patients with adrenal incidentalomas and Cushing's syndrome. Majnik J, Szücs N, Patócs A, Tóth M, Balogh K, Varga I, Gláz E, Rácz K. J Endocrinol Invest; 2004 Sep; 27(8):747-53. PubMed ID: 15636428 [Abstract] [Full Text] [Related]
46. Usefulness of cortisol/ACTH ratio (CAR) for diagnosis of cushing's syndrome: comparison of CAR with findings in dexamethasone suppression test. Iwamoto Y, Tatsumi F, Itoh T, Sasaki T, Mori S, Sugisaki T, Nakao E, Ohnishi M, Kusano T, Takenouchi H, Iwamoto H, Sanada J, Fushimi Y, Katakura Y, Kimura T, Shimoda M, Nakanishi S, Kaku K, Mune T, Kaneto H. Sci Rep; 2022 Oct 21; 12(1):17680. PubMed ID: 36271288 [Abstract] [Full Text] [Related]
48. The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome. Nieman LK, Chrousos GP, Oldfield EH, Avgerinos PC, Cutler GB, Loriaux DL. Ann Intern Med; 1986 Dec 21; 105(6):862-7. PubMed ID: 3022629 [Abstract] [Full Text] [Related]
49. Dexamethasone infusion testing in the diagnosis of Cushing's syndrome. Tran HA, Petrovsky N. Endocr J; 2005 Feb 21; 52(1):103-9. PubMed ID: 15758565 [Abstract] [Full Text] [Related]
50. Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Leibowitz G, Tsur A, Chayen SD, Salameh M, Raz I, Cerasi E, Gross DJ. Clin Endocrinol (Oxf); 1996 Jun 21; 44(6):717-22. PubMed ID: 8759185 [Abstract] [Full Text] [Related]
54. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB. J Clin Endocrinol Metab; 2003 Nov 21; 88(11):5299-306. PubMed ID: 14602765 [Abstract] [Full Text] [Related]
57. Comparison of 1 mg and 2 mg overnight dexamethasone suppression tests for the screening of Cushing's syndrome in obese patients. Sahin M, Kebapcilar L, Taslipinar A, Azal O, Ozgurtas T, Corakci A, Akgul EO, Taslipinar MY, Yazici M, Kutlu M. Intern Med; 2009 Nov 21; 48(1):33-9. PubMed ID: 19122354 [Abstract] [Full Text] [Related]
58. Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's Syndrome. Abe I, Sugimoto K, Miyajima T, Ide T, Minezaki M, Takeshita K, Takahara S, Nakagawa M, Fujimura Y, Kudo T, Miyajima S, Taira H, Ohe K, Ishii T, Yanase T, Kobayashi K. Intern Med; 2018 Sep 01; 57(17):2467-2472. PubMed ID: 29709936 [Abstract] [Full Text] [Related]
59. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit. Yap LB, Turner HE, Adams CB, Wass JA. Clin Endocrinol (Oxf); 2002 Jan 01; 56(1):25-31. PubMed ID: 11849243 [Abstract] [Full Text] [Related]
60. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome. Castro M, Elias LL, Elias PC, Moreira AC. Clin Endocrinol (Oxf); 2003 Dec 01; 59(6):800-5. PubMed ID: 14974925 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]